Dow Jones Industrial Average Battles Back on Homebuilder Optimism

2 Tech Titans at New Lows; Plus, 3 Earnings to Watch

Aug 17, 2015 at 11:52 AM
facebook twitter linkedin

The Dow Jones Industrial Average (DJIA) has battled back from an early triple-digit deficit and into positive territory, attempting to build on last week's momentum. It looks like the reversal is primarily data-driven, as a near-decade high in homebuilder confidence overshadows a six-year, post-recession low in the Empire State manufacturing survey -- not to mention crude's continued sell-off. Meanwhile, Wall Street is already getting amped up for this Wednesday, when the Fed will release its latest meeting minutes -- which could offer rate-hike timing clues.


Continue reading for more on today's market -- and don't miss:





Among the stocks with notable option volume is drugmaker AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), as the contracts are running at 125 times the usual midday rate.The company made waves earlier when it announced a global license agreement with Novartis AG (ADR) (NYSE:NVS). Currently, AVEO is up almost 55% at $1.81, and its October 2.50 call is seeing a mix of buy-to-open and sell-to-close activity, per the International Securities Exchange (ISE).


One of the top gainers on the Nasdaq is e-tailer Zulily Inc (NASDAQ:ZU), thanks to a buyout agreement with QVC parent Liberty Interactive Group (NASDAQ:QVCA). At last check, ZU has soared 46.7% to trade at $18.44.


One of the notable winners on the Big Board is Imprivata Inc (NYSE:IMPR), up 7.4% at $20.11 -- and fresh off a record high of $20.17. Sparking the sharp move north is a round of positive analyst attention for the healthcare firm.




The CBOE Volatility Index (VIX) is up 0.4 point, or 3%, at 13.22.


Today's put/call volume ratio on the SPDR S&P 500 ETF Trust (SPY) is 2.12, with puts more than doubling calls. SPY was last seen 0.5 point, or 0.2%, higher at $209.87.


If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial


Special Offers from Schaeffer's Trading Partners